Literature DB >> 7864701

High blood pressure. A side effect of drugs, poisons, and food.

E Grossman1, F H Messerli.   

Abstract

A variety of therapeutic agents or chemical substances can induce either a transient or a sustained increase in blood pressure. These agents increase arterial pressure by either causing sodium retention and extracellular volume expansion or directly or indirectly activating the sympathetic nervous system. Some agents act directly on arteriolar smooth muscle. For certain agents, the mechanism of pressure elevation is mixed or unknown. Paradoxically, some agents that are used to lower arterial pressure may acutely increase arterial pressure. Also, a rebound increase in pressure may be encountered after discontinuation of certain antihypertensive agents. In general, these chemically induced increases in arterial pressure are small and transient; however, severe hypertension involving encephalopathy, stroke, and irreversible renal failure has been reported. Careful evaluation of a patient's drug regimen may identify chemically induced hypertension and prevent the need for evaluation and therapy. This study reviews the therapeutic agents or chemical substances that elevate blood pressure and their mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864701     DOI: 10.1001/archinte.155.5.450

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

Review 1.  Drug-induced hypertension. Recognition and management in older patients.

Authors:  P W de Leeuw
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

2.  Hypertensive urgency: an important aetiology of rebound hypertension.

Authors:  John Malaty; Irene A Malaty
Journal:  BMJ Case Rep       Date:  2014-10-21

Review 3.  Drug-Induced Hypertension: Focus on Mechanisms and Management.

Authors:  Alexandra R Lovell; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 4.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

5.  Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.

Authors:  Michael L Maitland; George L Bakris; Henry R Black; Helen X Chen; Jean-Bernard Durand; William J Elliott; S Percy Ivy; Carl V Leier; Joann Lindenfeld; Glenn Liu; Scot C Remick; Richard Steingart; W H Wilson Tang
Journal:  J Natl Cancer Inst       Date:  2010-03-29       Impact factor: 13.506

Review 6.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

7.  Initial Management of Poisoned Patient.

Authors:  Jagadish Chandran; Bhuvana Krishna
Journal:  Indian J Crit Care Med       Date:  2019-12

8.  Drug-induced hypertension.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

Review 9.  Drug interactions and drugs that affect blood pressure.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.